Intensive blood pressure control reduces dementia risk
Analysis based on 10 articles · First reported Aug 30, 2026 · Last updated Sep 02, 2026
The positive results could boost demand for antihypertensive medications and encourage broader adoption of intensive blood pressure management, potentially expanding the market for these drugs. It may also influence clinical guidelines and reimbursement policies, benefiting pharmaceutical companies and healthcare providers focused on cardiovascular and cognitive health.
At ESC Congress 2026, results from the China Rural Hypertension Control Program (CRHCP) were presented showing that an intensive, community-based blood pressure lowering intervention reduced the incidence of dementia by 15% compared with usual care over seven years. The cluster-randomized trial enrolled 33,995 adults from 326 rural Chinese villages. The intervention, delivered by trained non-physician community healthcare providers under physician supervision, achieved a mean systolic blood pressure reduction of 17.6 mmHg versus 2.4 mmHg in the usual care group. Dementia occurred in 8.85% of the intervention group versus 10.55% in the usual care group (adjusted risk ratio 0.85; p<0.001). The intervention also reduced cognitive impairment without dementia by 13%. Serious adverse events were slightly less frequent in the intervention group. The findings support integrating structured blood pressure management into primary care as a scalable strategy for dementia prevention.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard